news

NEUROCATCH INC. RECEIVES MEDICAL DEVICE LICENSE FROM HEALTH CANADA FOR MOST RECENT PRODUCT ADVANCEMENT

NEUROCATCH INC. RECEIVES MEDICAL DEVICE LICENSE FROM HEALTH CANADA FOR MOST RECENT PRODUCT ADVANCEMENT

January 27, 2020

The NeuroCatch® Platform is an objective, rapid (~6 minutes) neuro-physiological brain function assessment system, that is commercially available to Canadian clinicians and healthcare professionals as a Licensed Medical Class II Device since early 2019 (MDL #102616). With our commitment to leading R&D, we are pleased to announce that Health Canada has awarded NeuroCatch Inc. a second Medical Device License for recent product advancements on the NeuroCatch™ Platform (version 1.1).

The NeuroCatch Platform is intended for the elicitation, acquisition, analysis, storage, reporting and management of event-related potential (ERP) information. The NCP 1.1 release offers the following product enhancements:

  • EEG Hardware Upgrade: Hardware design and robustness enhanced for high-volume and frequent usage.
  • Power Supply Upgrade: New devices issued with upgraded power supply for continuous charging.
  • Data Acquisition Software Upgrade: Upgrade of Data Acquisition Software implemented for repeat scanning.
Email: [email protected]
Phone: 1-844-847-1264
NeuroCatch Inc.
Unit 1009, City Centre 3
13761 96 Avenue, Surrey, BC V3V 0E8
Canada

ARTG number 439393 (Australia) Rx only (US)

The NeuroCatch® Platform is intended to be used in conjunction with other cognitive assessments and is not a diagnostic tool for a specific brain health condition. It is not to be used as a standalone diagnostic device.

Share